Etanercept works for psoriasis patients after they lose response to adalimumab

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
  • Patients with moderate-to-severe psoriasis who stopped responding to adalimumab (Humira) had a satisfactory response to etanercept (Enbrel) even if they had anti-adalimumab antibodies (ADA).
Why this matters
  • Some patients who take TNF inhibitor therapy lose response to them over time.